-

IFF’s Philippe Horvath Inducted into The National Inventors Hall of Fame

Molecular biologist honored for contributions to science, enhancing global food supply and laying the foundation for gene editing

NEW YORK--(BUSINESS WIRE)--Philippe Horvath—renowned molecular biologist and IFF technical fellow—is being inducted into the National Inventors Hall of Fame® Class of 2023. Horvath will be formally honored for two patents related to CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) sequences and associated Cas proteins, that constitute an acquired immune system in bacteria. Applying this research to enhance starter cultures in the dairy industry, Horvath and research partner Rodolphe Barrangou improved the world’s food supply and laid the foundation for the field of gene editing. The formal induction will take place during a ceremony in October 2023 in Washington, D.C.

“IFF congratulates Philippe on this unique recognition,” said Gregory Yep, chief research & development, global integrated solutions and sustainability officer. “We are proud of the achievements made by Philippe and the entire CRISPR team. It is a great testament to our heritage of scientific innovation and the ability to create a better world.”

Horvath’s initial article, published in Science in 2007, provided the first biological evidence that CRISPR-Cas constitutes an immunity system against viruses in bacteria. IFF scientists were among the first to understand how the CRISPR system works in bacteria. Beginning in the early 2000s, Horvath and colleagues initially utilized CRISPR for bacterial identification, then for its ability to improve the resistance of starter culture strains against bacteriophage attack. The discoveries opened new research avenues and laid the groundwork that inspired numerous scientists to pursue the CRISPR field.

“I am deeply honored to be selected by the National Inventors Hall of Fame to represent the pioneering work our team has done,” said Horvath. “Our findings, which were focused on the natural CRISPR-Cas system, will continue to have a significant impact in the fight against viral infections during food fermentations and are finding new applications in tools for genome editing, including opportunities in plant improvement and gene therapy.”

Based at IFF’s site in Dangé-Saint-Romain, France, Horvath already has been honored with four of the world’s leading science awards: the 2015 Massry Prize, the 2016 Warren Alpert Foundation Prize, the 2016 Canada Gairdner International Award, and the 2018 Bower Award and Prize for Achievement in Science.

Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com, Twitter, Facebook, Instagram, and LinkedIn.

© 2022 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

Contacts

Paula Heinkel
Head of Global Communications
332-877-5339
Media.request@iff.com

Michael Bender
Director of Investor Relations
212-708-7263
Investor.Relations@iff.com

IFF

NYSE:IFF

Release Versions

Contacts

Paula Heinkel
Head of Global Communications
332-877-5339
Media.request@iff.com

Michael Bender
Director of Investor Relations
212-708-7263
Investor.Relations@iff.com

More News From IFF

Tastepoint by IFF Predicts Ten Flavor Trends for 2026

PHILADELPHIA--(BUSINESS WIRE)--Tastepoint by IFF (NYSE: IFF), a leader in innovative flavor creations and taste solutions, has identified ten flavors expected to shape the North American food and beverage landscape in 2026. These predictions spotlight flavors anticipated to trend in retail, food service and beyond throughout the coming year. “To continue delivering product development solutions that meet consumers’ unique and changing needs, we stay attuned to industry and market trends, keepin...

IFF to Release Fourth Quarter & Full Year 2025 Results on Feb. 11, 2026; IFF to Present at 2026 CAGNY Conference on Feb. 19, 2026

NEW YORK--(BUSINESS WIRE)--IFF (NYSE:IFF) today announced that it will release its fourth quarter and full year 2025 earnings results following the market close on Wednesday, Feb. 11, 2026. The management team will host a live webcast on Thursday, Feb. 12, 2026, at 9:00 a.m. ET to discuss results and outlook with the investor community. IFF also announced today that the Company’s management will speak at the Consumer Analyst Group of New York (CAGNY) conference on Thursday, Feb. 19, 2026 at 1:0...

IFF Introduces Smart Dosing Robot to Transform Fragrance Production

CHIN BEE, Singapore--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences, has implemented the Colibri robot in its Chin Bee production facility. This advanced industrial dosing system can produce fragrance sample batches on demand in minutes, reimagining and expediting the fragrance development journey for local, regional and global customers in Greater Asia. The new robotic system, installed at the company's cross-category Scent a...
Back to Newsroom